Dihydroquercetin: pharmacological properties, possibility of using the drug in clinical practice

DOI: https://doi.org/10.29296/25877305-2022-10-16
Issue: 
10
Year: 
2022

Professor D. Dedov, MD
Tver State Medical University
Tver Regional Clinical Cardiology Dispensary

The paper presented a scientific review of 19 publications by authors from the Netherlands, the Russian Federation, Great Britain, China, India, South Korea, the United States, Egypt, and Slovakia. We studied: the pharmacological properties of dihydroquercetin. Reflected the antioxidant, anti-inflammatory, antimicrobial, antitumor effects of Dihydroquercetin on the human body. Shown the prospects of using dihydroquercetine in clinical practice: in patients with cardiovascular diseases, with diabetes, in oncology, neurology, surgery, in COVID-19
Keywords: 
dihydroquercetin
pharmacological properties
application
clinical practice

References: 
  1. Turck D., Bresson J.-L., Burlingame B. et al. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on taxifolin-rich extract from Dahurian Larch (Larix gmelinii). EFSA Journal. 2017; 15 (2): 4682. DOI: 10.2903/j.efsa.2017.4682
  2. Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008; 585 (2–3): 325–37. DOI: 10.1016/j.ejphar.2008.03.008
  3. Terekhov R.P. Influence of phase state on the physicochemical, technological and biopharmaceutical parameters of dihydroquercetin. Diss. … kand. med. nauk. М., 2021; 173 р. (in Russ.).
  4. Taldaev A., Terekhov R., Nikitin I. et al. Insights into the Pharmacological Effects of Flavonoids: The Systematic Review of Computer Modeling. Int J Mol Sci. 2022; 23 (11): 6023. DOI: 10.3390/ijms23116023
  5. Weidmann A.E. Dihydroquercetin: More than just an impurity? Eur J Pharmacol. 2012; 684 (1–3): 19–26. DOI: 10.1016/j.ejphar.2012.03.035
  6. Kovalevskaya E.G. Optimization of production conditions of Dihydroquercetin substance, development of a drug based on it. Avtoref. diss. … kand. med. nauk. Pyatigorsk, 2014; 24 р. (in Russ.).
  7. Sunil C., Xu B. An insight into the health-promoting effects of taxifolin (dihydroquercetin). Phytochemistry. 2019; 166: 112066. DOI: 10.1016/j.phytochem.2019.112066
  8. Alam Q., Krishnamurthy S. Dihydroquercetin ameliorates LPS-induced neuroinflammation and memory deficit. Curr Res Pharmacol Drug Discov. 2022; 3: 100091. DOI: 10.1016/j.crphar.2022.100091
  9. Islam J., Shree A., Vafa A. et al. Taxifolin ameliorates Benzo[a]pyrene-induced lung injury possibly via stimulating the Nrf2 signalling pathway. Int Immunopharmacol. 2021; 96: 107566. DOI: 10.1016/j.intimp.2021.107566
  10. Jiang W., Wei H., He B. Dietary flavonoids intake and the risk of coronary heart disease: a dose-response meta-analysis of 15 prospective studies. Thromb Res. 2015; 135 (3): 459–63. DOI: 10.1016/j.thromres.2014.12.016
  11. Kim Y., Je Y. Flavonoid intake and mortality from cardiovascular disease and all causes: A meta-analysis of prospective cohort studies. Clin Nutr ESPEN. 2017; 20: 68–77. DOI: 10.1016/j.clnesp.2017.03.004
  12. Liu Y.J., Zhan J., Liu X.L. et al. Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Clin Nutr. 2014; 33 (1): 59–63. DOI: 10.1016/j.clnu.2013.03.011
  13. Das A., Baidya R., Chakraborty T. et al. Pharmacological basis and new insights of taxifolin: A comprehensive review. Biomed Pharmacother. 2021; 142: 112004. DOI: 10.1016/j.biopha.2021.112004
  14. Chang S.C., Cassidy A., Willett W.C. et al. Dietary flavonoid intake and risk of incident depression in midlife and older women. Am J Clin Nutr. 2016; 104 (3): 704–14. DOI: 10.3945/ajcn.115.124545
  15. Zhu Y., Scholle F., Kisthardt S.C. et al. Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E. Virology. 2022; 571: 21–33. DOI: 10.1016/j.virol.2022.04.005
  16. Shhukina O.G. Experimental study of the wound-healing properties of dihydroquercetin in thermal skin injury. Avtoref. … diss. kand. biol. nauk. SPb, 2013; 28 р. (in Russ.).
  17. Hassan M.A., Tamer T.M., Valachová K. et al. Antioxidant and antibacterial polyelectrolyte wound dressing based on chitosan/hyaluronan/phosphatidylcholine dihydroquercetin. Int J Biol Macromol. 2021; 166: 18–31. DOI: 10.1016/j.ijbiomac.2020.11.119
  18. Zhang J., Chen K., Ding C. et al. Fabrication of chitosan/PVP/dihydroquercetin nanocomposite film for in vitro and in vivo evaluation of wound healing. Int J Biol Macromol. 2022; 206: 591–604. DOI: 10.1016/j.ijbiomac.2022.02.110
  19. Tyukavkina N.A., Rulenko I.A., Kolesnik Yu.A. Dihydroquercetin is a new antioxidant and biologically active food additive. Nutrition issues. 1997; 6: 12–5 (in Russ.).
  20. Plotnikov M.B., Logvinov S.V., Pugachenko N.V. et al. Cerebroprotective effects of a mixture of dicvertin and ascorbic acid. Pharmacology and toxicology. 2000; 130 (11): 543–7 (in Russ.).
  21. Plotnikov M.B., Tyukavkina N.A., Aliyev O.I., Maslov M.Yu., Alifirova V.M., Vasiliev A.S., Plotnikov D.M. Clinical efficacy of the new hemorheological drug «Askovertin» in patients with dyscirculatory encephalopathy. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2004; 12: 33–7 (in Russ.).
  22. Dorovskikh V.A., Tseluiko S.S., Simonova N.V., Anokhina R.A. In the world of antioxidants: a textbook. Blagoveshchensk: Amur State Medical Academy, 2012; 106 p. (in Russ.).
  23. Babkin V.A., Ostroukhova L.A., Levchuk A.A., et al. Effects of extraction conditions on the yield of native dihydroquercetin containing more than 97% (+)-2R,3R-trans isomer. Pharmaceutical Chemistry Journal. 2017; 51 (1): 39–41 (in Russ.).
  24. Xu Q., Parks C.G., DeRoo L.A. et al. Multivitamin use and telomere length in women. Am J Clin Nutr. 2009; 89 (6): 1857–63. DOI: 10.3945/ajcn.2008.26986